(Q43319924)

19 November 2017

title

The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis (English)

1 reference

19 November 2017

0 references

3

1 reference

19 November 2017

Anders Lasson

1

1 reference

19 November 2017

Per-Ove Stotzer

2

1 reference

19 November 2017

Stefan Isaksson

4

1 reference

19 November 2017

Maria Sapnara

5

1 reference

19 November 2017

Hans Strid

6

1 reference

19 November 2017

publication date

1 January 2015

1 reference

Journal of Crohn's and Colitis

19 November 2017

published in

1 reference

19 November 2017

volume

9

1 reference

19 November 2017

issue

1

1 reference

19 November 2017

page(s)

26-32

1 reference

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis

19 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Stool form scale as a useful guide to intestinal transit time

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.06.002

10.1016/J.CROHNS.2014.06.002

21 January 2018

Identifiers

DOI

1 reference

19 November 2017

1 reference